跳至主要内容
临床试验/IRCT201701291952N8
IRCT201701291952N8已完成2 期

The effect of ovarian stimulation with and without letrozole in improves in vitro fertilization outcome in low responder patients

Vice Chancellor for research, Tehran University of Medical Science0 个研究点目标入组 160 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 50 years(—)
性别
Female

入选标准

  • Inclusion criteria :infertile women with less than 3 oocyte; AMH <1, AFC<5 oocyte in each ovarian
  • Exclusion criteria:Other causes of infertility

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for research, Tehran University of Medical Science

相似试验

进行中(未招募)
1 期
Comparison of the difference in the number of oocytes obtained by administering the ovarian stimulation treatment as usually with administering it only once and later.
EUCTR2019-001343-44-ESInstituto Bernabeu180
已完成
不适用
Comparison of controlled ovarian stimulation with clomiphen citrate HMG(Human menopausal gonadotropin) or clomiphen citrate rFSH(recombinant follicule stimulating hormon) in IUI(Intrauterine Insemination) cycles.Condition 1: Unexplained infertility. Condition 2: Male factor infertility.Female infertility, unspecifiedOligospermia NOS
IRCT201109163386N4Semnan University of Medical Sciences142
已完成
不适用
effect of ovarian stimulation drugs on incidance of unruptured follicleCondition 1: luteinized unruptured follicle. Condition 2: luteinized unruptured follicle.Female infertility associated with anovulationFemale infertility, unspecified
IRCT2014091019113N1Tehran University Of Medical Sciences180
已完成
不适用
Comparing the effects of ovarian stimulation in infertile patientsinfertility.Female infertility
IRCT20221001056068N1Esfahan University of Medical Sciences26
进行中(未招募)
不适用
Fertility preservation in breast cancer patients: oocytes or embryos vitrification.The aim of this trial is to offer a safe and efficient alternative protocol to preserve fertility by storing oocytes in breast cancer patients before chemotherapy. Letrozole, an inhibitor of aromatase, is administered during standard gonadotropins ovarian stimulation to maintain a low estradiol level during ovarian stimulation in patients with hormono-sensitive tumour.MedDRA version: 18.1Level: LLTClassification code 10006190Term: Breast cancer invasive NOSSystem Organ Class: 100000004864MedDRA version: 18.1Level: LLTClassification code 10016465Term: Fertility female decreasedSystem Organ Class: 100000004872MedDRA version: 18.1Level: LLTClassification code 10016463Term: Fertility decreased femaleSystem Organ Class: 100000004872
EUCTR2012-003412-31-BECUB - Hôpital Erasme